Jung-Min Ahn , MD

Country Korea (Republic of)
Specialty Interventional Cardiologist
  1. VARIANT-ICD Trial: ICD vs. Medical Therapy Alone in Variant Angina With Aborted SCD
  2. FATE-MAIN Trial: FFR- vs. Angiography-guided Left Main PCI
  3. PREVENT Trial: Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque
  4. 15 Years History of TAVR in Asan Medical Center: Minimalist Intuitive Simple Approaches
  5. Bicuspid TAVR: All the Technical Issues and Data From Asan Medical Center
  6. Synergetic Approach for Discordant Lesions Between FFR and Non-Hyperemic Indexes
  7. The Fate of Deferred Lesions; Insight From the IRIS-FFR Registry
  8. Rule of 5-6-7-8 for Bifurcation PCI: It Is Time to Change in 2024
  9. Left Main AMI with Cardiogenic Shock, How to Rescue?
  10. Choosing Wisely: FFR vs. Anatomy Dilemma in LM PCI and Introduction to FATE-MAIN Trial
  11. Precision in Stent Sizing: Insights from Imaging-Guided LM PCI
  12. TAVR for Bicuspid AV: What’s Different?
  13. Synergetic Approach for Discordant Lesions Between FFR and Hyperemia Free Indexes
  14. ASSURE-DES Trial
  15. 10-Year Extended Follow-up of BEST Trial
  16. Defining Lesion Severity (by Angiography, Physiology & IVUS)
  17. Not to Treat
  18. Optimal MSA for LM Crush Technique: New Criteria Any Difference in Any 2 Stent Technique?
  19. TAVR Techniques in Bicuspid Anatomy – Valve Selection, Sizing, and Positioning
  20. How to Optimize 1st Valve Choice Matter for Future
  21. How Can We Treat Patients with Concomitant Coronary Artery Disease?
  22. Low Penetration of FFR (1A Class) in Real Practice; Why and How to Overcome?
  23. Case 4. CTO
  24. CTO Revascularization 2022: Guidelines and Concept Change
  25. Physiologic Approach For Non-LM Bifurcation Disease
  26. Unmet Need for FFR in LM PCI
  27. Minimalist TAVI : Achieving Great TAVI Efficiency and Optimal Patient Outcome
  28. 타비 시술을 위한 CT 평가
  29. TAVR for Bicuspid Valve: Practical Tips and Tricks for Optimal Sizing and Positioning
  30. FFR is a Routine Cath Lab Procedure
  31. FFR, It\'s Standard
  32. The Basics of Coronary Physiology Measurement: FFR, iFR and other NHPRs
  33. Updated Imaging/Physiology-Guided PCI Tuning 2021
  34. Under Pressure: Optimal Post-Dilation Strategy
  35. Difficult Wiring, Tips and Tricks
  36. TAVR for Bicuspid AS: Optimal Sizing & Valve Selection
  37. Imaging-guided PSP for Optimizing PCI
  38. How to Treat Tandem Lesion Under Physiology-Guidance
  39. Guide Extension Catheters: Strong Support from Mother-Child Relationship
  40. Post TAVR Coronary Access with Evolut System
  41. Self-Expandable Evolut R & PRO Valve
  42. TAVR for Bicuspid AV: Tips and Tricks
  43. Bifurcation PCI: Contemporary Practical Approach
  44. The Role of Debulking Atherectomy for Calcific In-stent Restenosis
  45. Prognosis of Discordant Lesion Between FFR and Hyperemia Free Indexes
  46. [Case-based Debate: Intracoronary Imaging Modalities for PCI Guidance] IVUS Is Better!
  47. Clinically Relevant PeriProcedural MI: Practical and Clinical Trial Aspect
  48. Case 1: Unexpanded ISR - Challenging and Optimal Treatment
  49. How Do I Implement?: FFR and Various Non-hyperemic Diastolic Index
  50. Current Status of Balloon-Expandable TAVR in Korea
  51. OAC in TAVR: FAILED GALILEO - NOAC Don\'t Work or Other Options?
  52. TAVR for Bicuspid AV: Tips and Tricks
  53. Synergetic Approach for Discordant Lesions Between FFR and Hyperemia Free Indexes
  54. Guide Extension Catheters: A Strong Support from a Parent-Child Relationship
  55. Expert Case Review: Complex PCI for Severe Calcified Coronary Disease
  56. Expert Case Review: Complex Bifurcation PCI
  57. Impact of Renal Function on Stroke or Systemic Embolism Following TAVR
  58. TAVR for Bicuspid Valve: Clinical Outcome and Technical Considerations
  59. TAVR: Bicuspid, Severe Calcium, and Low Lying Left Main
  60. TAVR in Bicuspid Aortic Stenosis with Severe Calcification: Case Reviews and Tips-and-Tricks
  61. How About Integrated Use of Resting Pd/Pa and FFR?
  62. Distal Left Main Bifurcation PCI: Concept Is More Important.
  63. [Case #2: Transcatheter Aortic Valve Implantation in a Patient with Type B Aortic Dissection] Part 2. How Would I Treat?
  64. FFR as the Gold Standard Index!
  65. Five-Year Outcomes of Routine FFR Use in Clinical Practice: Data from ASAN PCI Registry
  66. The Benefit of Complete Revascularization in Complex Coronary Artery Disease
  67. Asian Pacific TAVR Registry
  68. [Taped Case] TAVR with Evolut R
  69. Bicuspid AS: Future Perspectives of TAVR
  70. Integrated Use of FFR and IVUS for LM PCI
  71. Bicuspid TAVR Registry and TRANSIT Trial: TAVI Experience in AMC
  72. Bicuspid and Valve-in-Valve; How Different?
  73. Clinical Outcome of DEFER
  74. Left Main and MVD PCI: Imaging and Functional Guidance
  75. Utility of Intravascular Imaging for Resolving Issues During PCI
  76. Long Lesion and Tandem Lesion
  77. Bicuspid TAVR Registry
  78. AP TAVR Registry
  79. Current Status of TAVR: High/Intermediate and Lower Risk
  80. Clinical Impact of Routine FFR Measurement
  81. Tandem
  82. Prognostic Value of FFR: Insight from IRIS-FFR Registry
  83. Practical Aspect of IMR in AMI and Stable Angina
  84. Elderly Population
  85. LM PCI 2016: Integrated Approach Using IVUS, FFR and New Imaging Modality
  86. [Review in 2015] Physiology
  87. Tandem Lesion Evaluation
  88. Integrated Use of IVUS and FFR in Real Practice
  89. Readmission After PCI or CABG
  90. Left Main
  91. Final Answer RESTORE
  92. Comparative Outcomes of Various DES from IRIS-MAIN Registry and PRECOMBAT Series
  93. Case Presentation 4: Medically Stabilized Type A Aortic Dissection After TAVI
  94. Randomzed Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: Five-Year Outcomes of the PRECOMBAT Study
  95. Preliminary Data from IRIS FFR Registry
  96. Complex Lesions, Left Main, Bifurcations, Tandem, and More
  97. Left Main PCI
  98. Understanding About Visual-Functional Mismatching
  99. TAVI for Bicuspid Valve Stenosis
  100. FFR-guided PCI in Routine Practice: Learn from AMC Experiences
  101. Is There a Generation Gap of DES: Results of PRECOMBAT Study Series
  102. Clinical Implementation of FFR
  103. Case-based Review: Incidence and Treatment of LM ISR
  104. LM & Tandem Lesion
  105. VH IVUS: Native Plaque and Neointima
  106. Clinical Evidence of Neoatherosclerosis: ISR and Late Stent Thrombosis
  107. LM PCI
  108. IRIS-ELEMENT Data Review
  109. Cross and Perfect: 2013 Update
  110. Anatomical - Functional Stenosis: How Much Discordant?
  111. Case Presentation: Functional Angioplasty
  112. Impact of Functional Angioplasty on Clinical Outcomes of PCI
  113. Novice's Trial of Complex LM PCI
  114. New-generation DES for Long Lesions: From a Large-scale Cohort Regis
  115. FFR Utilization in LM PCI
  116. Promus Element Clinical Program in Asan Medical Center
  117. FFR-guided PCI in Tandem Lesion
  118. Two Cases with Coronary Thromboembolism
  119. Does the Timing of IABP Matter?